Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol

Autor: Astri Ferdiana, Liesbeth Mieras, Pushpendra Singh, Hana Krismawati, Astrid Irwanto, Teky Budiawan, Clara Imaniar, Tri Wahyuni, Arry Pongtiku

Publikováno v: BMJ Open, Vol 12, Iss 5 (2022)

Introduction The mainstay of leprosy treatment is multidrug treatment (MDT), which contains rifampicin, dapsone and clofazimine. The occurrence of dapsone hypersensitivity syndrome (DHS), a sudden, potentially fatal and traumatic adverse reaction due

Externí odkaz: https://doaj.org/article/e73ebd042de34e77b07c0f0ab5dccbaf

Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme

Autor: Jan Hendrik Richardus, ProfPhD, Anuj Tiwari, PhD, Tanja Barth-Jaeggi, PhD, Mohammad A Arif, MD, Nand Lal Banstola, MBA, Rabindra Baskota, MD, David Blaney, MD, David J Blok, PhD, Marc Bonenberger, PhD, Teky Budiawan, MD, Arielle Cavaliero, MPH, Zaahira Gani, MSc, Helena Greter, PhD, Eliane Ignotti, ProfPhD, Deusdedit V Kamara, MD, Christa Kasang, PhD, Pratap R Manglani, MD, Liesbeth Mieras, MD, Blasdus F Njako, MD, Tiara Pakasi, MA, Basu Dev Pandey, PhD, Paul Saunderson, PhD, Rajbir Singh, MD, W Cairns S Smith, ProfPhD, René Stäheli, MSc, Nayani D Suriyarachchi, MD, Aye Tin Maung, MD, Tin Shwe, MD, Jan van Berkel, MA, Wim H van Brakel, PhD, Bart Vander Plaetse, MD, Marcos Virmond, ProfPhD, Millawage S D Wijesinghe, MD, Ann Aerts, MD, Peter Steinmann, PhD

Publikováno v: The Lancet Global Health, Vol 9, Iss 1, Pp e81-e90 (2021)

Summary: Background: Innovative approaches are required for leprosy control to reduce cases and curb transmission of Mycobacterium leprae. Early case detection, contact screening, and chemoprophylaxis are the most promising tools. We aimed to generat

Externí odkaz: https://doaj.org/article/c85388dc97ed4ea2b1c56421e7940d48

The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis

Autor: Wim H. van Brakel, Teky Budiawan, Anne Schoenmakers, Liesbeth Mieras

Publikováno v: Research and Reports in Tropical Medicine. 11:97-117

Objective Annually, over 200,000 people are diagnosed with leprosy, also called Hansen's disease. This number has been relatively stable over the past years. Progress has been made in the fields of chemoprophylaxis and immunoprophylaxis to prevent le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f0dac14b423a94c6b4dee0ee245610f3
https://doi.org/10.2147/rrtm.s190300

The long-term impact of the leprosy post-exposure prophylaxis (Lpep) program on leprosy incidence: a modelling study

Autor: Christa Kasang, David D. Blaney, Mohammad Arif, David J. Blok, Tin Shwe, Pratap R. Manglani, Marc Bonenberger, Jan van Berkel, Marcos Virmond, Wim H. van Brakel, Zaahira Gani, Tiara Pakasi, Paul Saunderson, Millawage Supun Dilara Wijesinghe, Deusdedit V. Kamara, Anuj Tiwari, Aye Tin Maung, Helena Greter, Tanja Barth-Jaeggi, Teky Budiawan, Nand Lal Banstola, Bart Vander Plaetse, Liesbeth Mieras, Rabindra Baskota, Eliane Ignotti, Arielle Cavaliero, Nayani D. Suriyarachchi, Ann Aerts, Blasdus Njako, W. Cairns S. Smith, René Stäheli, Unnati Rani Saha, Jan Hendrik Richardus, Peter Steinmann

Publikováno v: PLoS Neglected Tropical Diseases, 15(3):e0009279. Public Library of Science
PLoS Neglected Tropical Diseases, Vol 15, Iss 3, p e0009279 (2021)
PLoS Neglected Tropical Diseases

Background The Leprosy Post-Exposure Prophylaxis (LPEP) program explored the feasibility and impact of contact tracing and the provision of single dose rifampicin (SDR) to eligible contacts of newly diagnosed leprosy patients in Brazil, India, Indone

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9988195604d4cc6dbc221a81fcef0819
https://pure.eur.nl/en/publications/c3745bda-afd2-4abc-bb5c-58076c8303b0

Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme

Autor: Eliane Ignotti, Marc Bonenberger, Millawage Supun Dilara Wijesinghe, Christa Kasang, Rabindra Baskota, Jan Hendrik Richardus, Helena Greter, Deusdedit V. Kamara, René Stäheli, Tin Shwe, Aye Tin Maung, Bart Vander Plaetse, Teky Budiawan, Wim H. van Brakel, Anuj Tiwari, Pratap R. Manglani, Marcos Virmond, Mohammad Arif, Jan van Berkel, Tanja Barth-Jaeggi, Tiara Pakasi, Zaahira Gani, David J. Blok, David D. Blaney, Nand Lal Banstola, Ann Aerts, Blasdus Njako, Rajbir Singh, Liesbeth Mieras, W. Cairns S. Smith, Basu Dev Pandey, Paul Saunderson, Peter Steinmann, Arielle Cavaliero, Nayani D. Suriyarachchi

Publikováno v: The Lancet Global Health, Vol 9, Iss 1, Pp e81-e90 (2021)
The Lancet Global Health, 9(1), e81-e90. Elsevier

Summary Background Innovative approaches are required for leprosy control to reduce cases and curb transmission of Mycobacterium leprae. Early case detection, contact screening, and chemoprophylaxis are the most promising tools. We aimed to generate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64d5a93daa55b87b04739f44dd7b1a9
https://pubmed.ncbi.nlm.nih.gov/33740406